Cookie Img
Back to top
Home » Products » Bulk Drugs (APIs) » Doxazosin mesylate

Doxazosin mesylate

Doxazosin mesylate
Doxazosin mesylate
Product Code : 145
Product Description

Doxazosin mesylate
Synonyms : Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-,methanesulfonate (1:1)

CAS No.:   77883-43-3

Formula:  C24H29N5O8S

Molecular Weight:   547.58

Melting Point:  275-277 °C

Boiling Point:   718 °C at 760 mmHg

Flash Point:   388 °C

Appearance:   White crystalline powder

Specifications

Purity  : ≥99%

Appearance  : white crystalline powder

Storage:  Store at 4° C

Form:   Solid

Solubility:   Solubility: Slightly soluble in water.

Melting Point:   275-277°C

Boling Point:  718ºC

Flash Point:  388ºC

Density:  1.371 g/cm3

Description

Doxazosin Mesylate is an alpha-blocker drug related to prazosin, specifically acting as an alpha-1-adrenoceptor antagonist. Doxazosin Mesylate inhibits the binding of norepinephrine to the alpha-1 receptors on the membrane of vascular smooth muscle cells. The primary effect of this inhibition is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure.

Synonyms : Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-,methanesulfonate (1:1)

CAS No.:   77883-43-3

Formula:  C24H29N5O8S

Molecular Weight:   547.58

Melting Point:  275-277 °C

Boiling Point:   718 °C at 760 mmHg

Flash Point:   388 °C

Appearance:   White crystalline powder

Specifications

Purity  : ≥99%

Appearance  : white crystalline powder

Storage:  Store at 4° C

Form:   Solid

Solubility:   Solubility: Slightly soluble in water.

Melting Point:   275-277°C

Boling Point:  718ºC

Flash Point:  388ºC

Density:  1.371 g/cm3

Description

Doxazosin Mesylate is an alpha-blocker drug related to prazosin, specifically acting as an alpha-1-adrenoceptor antagonist. Doxazosin Mesylate inhibits the binding of norepinephrine to the alpha-1 receptors on the membrane of vascular smooth muscle cells. The primary effect of this inhibition is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure.